AIM: Sleeve gastrectomy (SG) and modified duodenal jejunal bypass (MDJB) were compared as procedures for glucose control. We aim to form the initial conclusions with respect to the possibility of (1) whether gastric fundus exclusion is essential for the control of diabetes and (2) application as a low morbidity procedure. MATERIALS AND METHODS: SG and MDJB were performed on 10- to 12-week-old Goto-Kakizaki rats that spontaneously develop type 2 diabetes. Rats were observed for 36 weeks after surgery, and glucose, insulin, glucagons-like peptide-1 (GLP-1), glucose tolerate, insulin sensitivity, cholesterol, triglycerides, and free fatty acid levels were measured. RESULTS: Apart from distinct weight loss of SG and MDJB after 1 month compared with sham-operated rats (P < 0.001), SG showed strikingly improved blood glucose levels and significantly decreased Ghrelin secretion (P < 0.001). Furthermore, SG resulted in a shorter operative time (P < 0.01) and postoperative recovery time (P < 0.01) than MDJB group. CONCLUSIONS: SG shows better control in terms of glucose tolerance and other measurements. This study provides direct evidence that SG possesses better improvement of diabetes by reduction of Ghrelin.
AIM: Sleeve gastrectomy (SG) and modified duodenal jejunal bypass (MDJB) were compared as procedures for glucose control. We aim to form the initial conclusions with respect to the possibility of (1) whether gastric fundus exclusion is essential for the control of diabetes and (2) application as a low morbidity procedure. MATERIALS AND METHODS: SG and MDJB were performed on 10- to 12-week-old Goto-Kakizaki rats that spontaneously develop type 2 diabetes. Rats were observed for 36 weeks after surgery, and glucose, insulin, glucagons-like peptide-1 (GLP-1), glucose tolerate, insulin sensitivity, cholesterol, triglycerides, and free fatty acid levels were measured. RESULTS: Apart from distinct weight loss of SG and MDJB after 1 month compared with sham-operated rats (P < 0.001), SG showed strikingly improved blood glucose levels and significantly decreased Ghrelin secretion (P < 0.001). Furthermore, SG resulted in a shorter operative time (P < 0.01) and postoperative recovery time (P < 0.01) than MDJB group. CONCLUSIONS: SG shows better control in terms of glucose tolerance and other measurements. This study provides direct evidence that SG possesses better improvement of diabetes by reduction of Ghrelin.
Authors: B Detournay; S Cros; B Charbonnel; A Grimaldi; F Liard; J Cogneau; F Fagnani; E Eschwège Journal: Diabetes Metab Date: 2000-11 Impact factor: 6.041
Authors: Efstathios V Kotidis; George G Koliakos; Vasilios G Baltzopoulos; Konstantinos N Ioannidis; John G Yovos; Spiros T Papavramidis Journal: Obes Surg Date: 2006-11 Impact factor: 4.129
Authors: N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli Journal: World J Surg Date: 1998-09 Impact factor: 3.352
Authors: J Galli; L S Li; A Glaser; C G Ostenson; H Jiao; H Fakhrai-Rad; H J Jacob; E S Lander; H Luthman Journal: Nat Genet Date: 1996-01 Impact factor: 38.330
Authors: Alberto Patriti; Maria Cristina Aisa; Claudia Annetti; Angelo Sidoni; Francesco Galli; Ivana Ferri; Nino Gullà; Annibale Donini Journal: Surgery Date: 2007-07 Impact factor: 3.982
Authors: Tammy L Kindel; Paulo J F Martins; Stephanie M Yoder; Ronald J Jandacek; Randy J Seeley; David A D'Alessio; Silvana Obici; Patrick Tso Journal: Obesity (Silver Spring) Date: 2010-10-28 Impact factor: 5.002
Authors: Eun Kyung Lee; So Young Kim; You Jin Lee; Mi Hyang Kwak; Hak Jin Kim; Il Ju Choi; Soo-Jeong Cho; Young Woo Kim; Jong Yeul Lee; Chan Gyoo Kim; Hong Man Yoon; Bang Wool Eom; Sun-Young Kong; Min Kyong Yoo; Jong Hyock Park; Keun Won Ryu Journal: World J Gastroenterol Date: 2015-01-28 Impact factor: 5.742
Authors: Marta Guimarães; Mário Nora; Tiago Ferreira; Sara Andrade; Andreia M Ribeiro; Vera Oliveira; Marcos C Carreira; Felipe F Casanueva; Mariana P Monteiro Journal: Obes Surg Date: 2013-05 Impact factor: 4.129